These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30773756)

  • 61. Single-arm, first-in-human feasibility study results for an ultra-low-cost insulin pump.
    Payne M; Pooke F; Wilkinson TM; Holder-Pearson L; Chamberlain B; de Bock M; Chase JG
    BMC Endocr Disord; 2024 Aug; 24(1):134. PubMed ID: 39090697
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Benefits and Challenges of Diabetes Technology Use in Older Adults.
    Toschi E; Munshi MN
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):57-67. PubMed ID: 31980121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Socio-economic disparities in hospital care among Dutch patients with diabetes mellitus.
    de Vries SAG; Sas TCJ; Bak JCG; Mul D; Nieuwdorp M; Wouters MWJM; Verheugt CL
    Diabetes Obes Metab; 2024 Apr; 26(4):1386-1394. PubMed ID: 38229451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management.
    Fritzen K; Basinska K; Rubio-Almanza M; Nicolucci A; Kennon B; Vergès B; Zakrzewska K; Schnell O
    J Diabetes Sci Technol; 2019 Nov; 13(6):1112-1122. PubMed ID: 30917691
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of free medical supplies and regular telephonic contact on glycemic control in Indian children and adolescents with type 1 diabetes.
    Chopra A; Sudhanshu S; Chen Y; Mangla P; Dabadghao P; Bhatia E; Arora P; Bano S; Bhatia V
    Pediatr Diabetes; 2019 Jun; 20(4):444-449. PubMed ID: 30861594
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glycaemic control in patients with type 1 diabetes after provision of public hospital-funded insulin pumps.
    Thong KY; Fegan PG; Yeap BB
    Med J Aust; 2009 Sep; 191(5):291. PubMed ID: 19740060
    [No Abstract]   [Full Text] [Related]  

  • 67. Psychosocial Aspects of Diabetes Technology Use: The Child and Family Perspective.
    Papadakis JL; Anderson LM; Garza K; Feldman MA; Shapiro JB; Evans M; Thompson LG; Weissberg-Benchell J
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):127-141. PubMed ID: 31980113
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transforming type 1 diabetes: the next wave of innovation.
    Drucker DJ
    Diabetologia; 2021 May; 64(5):1059-1065. PubMed ID: 33550440
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. USA Vs Europe: Who Is Leading the Diabetes Tech Race?
    Acosta GJ; Brown S; Zand AM; Kansara A; Sadhu A
    Curr Diab Rep; 2019 Nov; 19(11):128. PubMed ID: 31734741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring.
    Grunberger G; Bailey T; Camacho PM; Einhorn D; Garber AJ; Handelsman Y; Harrell RM; Lando HM; Law B; Leffert JD; Orzeck EA;
    Endocr Pract; 2015 May; 21(5):522-33. PubMed ID: 25962091
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Psychosocial Aspects of Diabetes Technology: Adult Perspective.
    Polonsky WH
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):143-155. PubMed ID: 31980114
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of reimbursement in the adoption of continuous glucose monitors.
    Bartelme A; Bridger P
    J Diabetes Sci Technol; 2009 Jul; 3(4):992-5. PubMed ID: 20144351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Self-reported insulin pump prescribing practices in pediatric type 1 diabetes.
    Fredette ME; Zonfrillo MR; Park S; Quintos JB; Gruppuso PA; Topor LS
    Pediatr Diabetes; 2021 Aug; 22(5):758-765. PubMed ID: 33855806
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey.
    Dos Santos TJ; Dave C; MacLeish S; Wood JR
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34845060
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Future of diabetes-technology: certificate of competency for insulin pumps and continuous glucose monitors.
    Heinemann L; Faber-Heinemann G; Roberts R; Walsh J
    J Diabetes Sci Technol; 2012 Jul; 6(4):725-7. PubMed ID: 22920796
    [No Abstract]   [Full Text] [Related]  

  • 77. Glycaemic control in patients with type 1 diabetes after provision of public hospital-funded insulin pumps.
    Goss PW
    Med J Aust; 2010 Jan; 192(2):107-8. PubMed ID: 20078414
    [No Abstract]   [Full Text] [Related]  

  • 78. Demanding devices - Living with diabetes devices as a pre-teen.
    Pals RAS; Hviid P; Cleal B; Grabowski D
    Soc Sci Med; 2021 Oct; 286():114279. PubMed ID: 34428602
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Glucose sensors, insulin pumps and smart pens are growing together - A clinical update to modern diabetes technology].
    Gehr B
    MMW Fortschr Med; 2020 Dec; 162(21-22):69-75. PubMed ID: 33319293
    [No Abstract]   [Full Text] [Related]  

  • 80. [Insulin pump treatment in children and adolescents with type 1 diabetes].
    Bittner C; von Schütz W; Danne T
    MMW Fortschr Med; 2004 May; 146(20):35-7. PubMed ID: 15344731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.